Latest News:

TIF

Ruxolitinib

An agent that regulates hemoglobin gene expression, used for the treatment of other haematological c...
LentiGlobin gene therapy

Autologous CD34+ cells transduced with the BB305 lentiviral vector. An initial phase 1/2 study [Nort...
NTWS organized the 9th National Thalassaemia Conference in New Delhi

...
Sir David Weatherall, an ‘iconic’ scientist who carried out groundbreaking work in thalassaemia, dies

...
TIF SURVEY – State provided social benefits for people with thalassaemia

...

Highlights APERÇUS IN EVIDENZA أخبار مهمة Κυριότερα Σημεία Highlights

TIF e-AcademyAcadémie électronique de la FITe-Academyالأكاديمية الإلكترونيةΗλεκτρονική ΑκαδημίαTIF e-Akademie

ConferencesConférencesConferenzeالمؤتمراتΣυνέδριαKonferenzen

Patients' StoriesRécits de patientsStorie di pazientiقصص يرويها المرضىΙστορίες ΑσθενώνErfahrungsberichte von Patienten

Clinical Trial UpdatesEssais cliniques - Mises à jourAggiornamenti sugli studi cliniciآخر مستجدات التجارب السريريةΕνημερώσεις για κλινικές δοκιμέςUpdate zu klinischen Studien

Renzo Galanello FellowshipsBourses Renzo GalanelloBorsa di studio Renzo Galanelloمنحة رينزو جالانيلوΥποτροφίες Renzo GalanelloRenzo Galanello Stipendien

International Thalassaemia DayJournée Mondiale de la ThalassémieGiornata internazionale della talassemiaاليوم العالمي ’للثلاسيميا’Παγκόσμια Ημέρα ΘαλασσαιμίαςInternationaler Tag der Thalassämie

Thalassaemia Patients ConnectInterconnexion des patients atteints de thalassémiePazienti talassemici connessiالتواصل فيما بين مرضى ’الثلاسيميا’Πλατφόρμα Thalassaemia Patients ConnectThalassämie-Patienten Connect

CommunicationsCommunicationsComunicazioniWORDΜέσα επικοινωνίαςKommunikation

Supporters Sympathisants Sostenitori الداعمون Οι Υποστηρικτές μας Unterstützer